Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-08 09:10 am Sale | 2024-03-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 95,000 0.110% | -10,621,153 (-99.11%) | Filing History |
| 2024-03-25 5:29 pm Sale | 2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,716,153 12.650% | -170,000 (-1.56%) | Filing History |
| 2024-03-20 6:08 pm Unchanged | 2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 4.500% | 0 (Unchanged) | Filing History |
| 2024-03-07 4:05 pm Unchanged | 2024-03-07 | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 5.300% | 0 (Unchanged) | Filing History |
| 2024-02-14 06:00 am Unchanged | 2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 4.300% | 0 (Unchanged) | Filing History |
| 2024-02-13 9:34 pm Sale | 2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | Avidity Partners Management LP | 6,500,328 8.100% | -324,122 (-4.75%) | Filing History |
| 2024-02-09 09:03 am Purchase | 2024-02-08 | 13G | Fusion Pharmaceuticals Inc. FUSN | FMR LLC | 5,313,294 7.338% | 2,621,240 (+97.37%) | Filing History |
| 2024-01-19 4:37 pm Purchase | 2024-01-09 | 13G | Fusion Pharmaceuticals Inc. FUSN | Perceptive Advisors LLC | 4,737,194 6.500% | 4,737,194 (New Position) | Filing History |
| 2024-01-18 10:11 am Purchase | 2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,886,153 15.030% | 252,364 (+2.37%) | Filing History |
| 2023-12-18 4:45 pm Purchase | 2023-12-14 | 13G | Fusion Pharmaceuticals Inc. FUSN | James E. Flynn | 6,401,000 8.840% | 6,401,000 (New Position) | Filing History |
| 2023-10-23 5:20 pm Purchase | 2023-10-18 | 13G | Fusion Pharmaceuticals Inc. FUSN | Avidity Partners Management LP | 6,824,450 9.700% | 6,824,450 (New Position) | Filing History |
| 2023-06-09 08:19 am Purchase | 2023-05-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,633,789 16.660% | 7,409,689 (+229.82%) | Filing History |
| 2023-05-16 4:28 pm Unchanged | 2023-05-11 | 13D | Fusion Pharmaceuticals Inc. FUSN | ORBIMED ADVISORS LLC | 2,930,670 4.600% | 0 (Unchanged) | Filing History |
| 2023-03-06 4:06 pm Unchanged | 2023-02-16 | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 6.100% | 0 (Unchanged) | Filing History |
| 2023-02-28 5:09 pm Sale | 2023-02-16 | 13D | Fusion Pharmaceuticals Inc. FUSN | ORBIMED ADVISORS LLC | 2,930,670 4.700% | -67,311 (-2.25%) | Filing History |
| 2023-02-09 10:59 am Sale | 2023-02-09 | 13G | Fusion Pharmaceuticals Inc. FUSN | FMR LLC | 2,692,054 6.014% | -537,912 (-16.65%) | Filing History |
| 2023-02-01 08:56 am Purchase | 2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 3,224,100 7.200% | 3,224,100 (New Position) | Filing History |
| 2023-01-27 11:12 am Sale | 2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | JOHNSON & JOHNSON JNJ | 3,670,516 8.200% | -89,118 (-2.37%) | Filing History |
| 2022-02-14 2:51 pm Sale | 2021-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | Adams Street Partners, LLC | 2,947,809 6.800% | -544,940 (-15.60%) | Filing History |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Fusion Pharmaceuticals Inc. FUSN | FMR LLC | 3,229,966 7.499% | 100,532 (+3.21%) | Filing History |